Real-time Euronext Paris 10:19:29 2024-04-25 am EDT 5-day change 1st Jan Change
82.8 EUR -1.72% Intraday chart for Eurazeo SE +1.72% +15.24%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tikehau Capital: 13% increase in assets under management in Q1 CF
Eurazeo: agreement to invest in Eres Group CF
Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024. CI
Arielle Zuckerberg firm invests in French space tech company Dark RE
SAS DARK announced that it has received $11 million in funding from Eurazeo SE, Otium Capital, Kima Ventures SAS, Long Journey Ventures, Frst Capital CI
SAS DARK announced that it has received $6 million in funding from Eurazeo SE, Long Journey Ventures CI
Carl Zeiss Meditec expands ophthalmology portfolio through acquisition DP
Eurazeo Completes Sale of Medical Device Company to Carl Zeiss Meditec MT
Eurazeo: finalizes sale of DORC CF
Carl Zeiss Meditec AG completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF). CI
Eurazeo SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qoala announced that it has received $47 million in funding from a group of investors CI
EURAZEO : Berenberg raises target, maintains buy recommendation CF
Eurazeo: the stock outperforms, an analyst raises his target CF
Eurazeo: agreement for the sale of Peters Surgical CF
Advanced Medical Solutions Group to Buy Peters Surgical MT
PPRO Financial Ltd announced that it has received $92.8 million in funding from a group of investors CI
Advanced Medical Solutions Group plc entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for ?140 million. CI
EURAZEO : Eurazeo stays the course and rewards its shareholders Alphavalue
Eurazeo SE Proposes Ordinary Dividend for the Year 2023 CI
Transcript : Eurazeo SE, 2023 Earnings Call, Mar 07, 2024
Eurazeo: annual RNPG breakeven excluding exceptional items CF
Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for ?200 million worth of its shares. CI
Tranche Update on Eurazeo SE (ENXTPA:RF)'s Equity Buyback Plan announced on March 8, 2023. CI
Eurazeo: Adrien Pinelli strengthens Middle East team CF
Chart Eurazeo SE
More charts
Eurazeo SE is a leading European investment group with diversified assets under management of EUR 35 billion, including EUR 24.2 billion on behalf of institutional and individual clients through its private equity, private debt, real estate and infrastructure strategies. The group supports over 600 mid-market companies, leveraging the commitment of its 400 employees, its sector expertise, its privileged access to global markets via 12 offices in Europe, Asia and the United States, and its responsible approach to value creation based on growth. Eurazeo's institutional and family shareholding and its solid financial structure ensure its long-term viability. Eurazeo SE has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Saõ Paulo.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
84.25 EUR
Average target price
93.5 EUR
Spread / Average Target
+10.98%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. RF Stock
  4. News Eurazeo SE
  5. Eurazeo To Divest Majority Stake In Fragrance Lifestyle Brand NEST New York